| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.42 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |